Jeff Bissen is a seasoned business development leader currently serving as Senior Director of Business Development at Ncardia since 2024, where responsibilities include driving the commercial growth of induced pluripotent stem cell (iPSC) products and facilitating partnerships for cell therapies. Prior to this role, Jeff held multiple positions at Synthego Corporation from 2020 to 2023, culminating as Global Strategic Account Manager, with a track record of promotions and mentoring junior team members. Jeff also operated as a consultant at Synaptigen, LLC, specializing in career coaching and sales training, and has held scientific sales and research roles in biotechnology firms, contributing to publications and achieving sales targets. Educational accomplishments include a Bachelor of Science from the University of Minnesota and a CRISPR Certificate from Harvard University.